Discordant use of short-acting β₂ agonists in children and adults with severe, uncontrolled asthma from the U-BIOPRED cohort

Affiliations

• ¹ Department of Pulmonology, University Children's Hospital (UKBB), University of Basel, Basel, Switzerland.
• ² National Heart and Lung Institute, Imperial College London, London, UK.
• ³ Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
• ⁴ Clinical and Experimental Sciences and Human Development and Health, Faculty of Medicine, University of Southampton, UK and NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
• ⁵ U-BIOPRED Patient Input Platform, ELF, Sheffield, UK.
• ⁶ Department of Paediatric Respiratory Medicine, Children's University Hospital of Bern, University of Bern, Bern, Switzerland.
• ⁷ Respiratory Therapeutic Unit, GSK, London, UK.
• ⁸ Respiratory Global Medicines Development, AstraZeneca BioPharmaceuticals R&D, Gothenburg, Sweden.